Prati
Anguraj Sadanandam
Naslov
Citirano
Citirano
Godina
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
45342015
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
EA Collisson, A Sadanandam, P Olson, WJ Gibb, M Truitt, S Gu, J Cooc, ...
Nature medicine 17 (4), 500-503, 2011
17332011
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ...
Science 359 (6378), 920-926, 2018
14722018
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
A Sadanandam, CA Lyssiotis, K Homicsko, EA Collisson, WJ Gibb, ...
Nature medicine 19 (5), 619-625, 2013
10712013
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
A Kapoor, W Yao, H Ying, S Hua, A Liewen, Q Wang, Y Zhong, CJ Wu, ...
Cell 158 (1), 185-197, 2014
6952014
Subtype and pathway specific responses to anticancer compounds in breast cancer
LM Heiser, A Sadanandam, WL Kuo, SC Benz, TC Goldstein, S Ng, ...
Proceedings of the National Academy of Sciences 109 (8), 2724-2729, 2012
5382012
Inter‐and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
C Neuzillet, A Tijeras‐Raballand, C Ragulan, J Cros, Y Patil, M Martinet, ...
The Journal of pathology 248 (1), 51-65, 2019
2552019
Chemokines in tumor angiogenesis and metastasis
S Singh, A Sadanandam, RK Singh
Cancer and Metastasis Reviews 26, 453-467, 2007
2322007
Genomic and transcriptomic determinants of therapy resistance and immune landscape evolution during anti-EGFR treatment in colorectal cancer
A Woolston, K Khan, G Spain, LJ Barber, B Griffiths, R Gonzalez-Exposito, ...
Cancer cell 36 (1), 35-50. e9, 2019
2042019
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis
S Singh, A Sadanandam, KC Nannuru, ML Varney, R Mayer-Ezell, ...
Clinical Cancer Research 15 (7), 2380-2386, 2009
1772009
ATR inhibition potentiates the radiation-induced inflammatory tumor microenvironment
MT Dillon, KF Bergerhoff, M Pedersen, H Whittock, E Crespo-Rodriguez, ...
Clinical Cancer Research 25 (11), 3392-3403, 2019
1602019
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics
A Sadanandam, S Wullschleger, CA Lyssiotis, C Grötzinger, S Barbi, ...
Cancer discovery 5 (12), 1296-1313, 2015
1602015
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer
Z Hu, G Huang, A Sadanandam, S Gu, ME Lenburg, M Pai, N Bayani, ...
Breast cancer research 12, 1-15, 2010
1582010
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
S Singh, KC Nannuru, A Sadanandam, ML Varney, RK Singh
British journal of cancer 100 (10), 1638-1646, 2009
1442009
Molecular subtypes in cancers of the gastrointestinal tract
MF Bijlsma, A Sadanandam, P Tan, L Vermeulen
Nature reviews Gastroenterology & hepatology 14 (6), 333-342, 2017
1242017
Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis
A Sadanandam, EG Rosenbaugh, S Singh, M Varney, RK Singh
Microvascular research 79 (1), 1-9, 2010
1202010
Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
E Fontana, K Eason, A Cervantes, R Salazar, A Sadanandam
Annals of Oncology 30 (4), 520-527, 2019
1122019
Cathepsin G Enhances Mammary Tumor–Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-κb Ligand
TJ Wilson, KC Nannuru, M Futakuchi, A Sadanandam, RK Singh
Cancer research 68 (14), 5803-5811, 2008
1042008
Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications
A Sadanandam, X Wang, F de Sousa E Melo, JW Gray, L Vermeulen, ...
Cell cycle 13 (3), 353-357, 2014
962014
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify …
NJ Battersby, M Dattani, S Rao, D Cunningham, D Tait, R Adams, ...
Trials 18, 1-14, 2017
862017
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20